Satellos Bioscience Inc share price logo

Satellos Bioscience Inc Share Price

NASDAQ: MSLE

Small Cap

$6.20

-0.73

(-10.53%)

as on

Satellos Bioscience Inc Stock Performance

as on March 28, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $6.10
    $7.00
    downward going graph

    1.61%

    Downside

    12.90%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Satellos Bioscience Inc share price movements today

Previous Close
$6.93
Open
$7.00
Volume
225.0K
Day's Low - High
$6.10 - $7.00

Satellos Bioscience Inc Historical Returns

1 Month Return
-49.88 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Satellos Bioscience Inc Stock Fundamentals & Key Indicators

Check Satellos Bioscience Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$144.1M

EPS (TTM)

-1.8

Dividend Yield

0.00%

PE Ratio (TTM)

2.7

PEG Ratio

0

Return On Equity TTM

-87.59%

Satellos Bioscience Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Satellos Bioscience Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$144.1MNA2.70.00%
BUY$43.5B132.92%140.848.45%
BUY$115.2B101.77%29.5832.94%
NA$31.8BNA112.585.37%
BUY$80.0B54.69%18.2531.41%

Satellos Bioscience Inc Stock’s Investor Sentiment and Interest

Search interest for Satellos Bioscience Inc Stock has increased by 1300% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1300% versus previous 30 day period

Satellos Bioscience Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Income
-3
-4
-6
-6
-5
EBITDA
-3
-3
-6
-6
-5
Interest Expense
-
-
-
-
-
Depreciation
0
0
0
-
0
Income Before Tax
-6
-3
-6
-5
-5
Income Tax Expense
-
-
0
0
0
Net Income
-6
-2
-6
-5
-5
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Satellos Bioscience Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
Gross Profit
0
-
-
-
Operating Income
-3
-6
-11
-19
EBITDA
-11
-8
-11
-19
Interest Expense
0
-
0
-
Depreciation
0
0
0
0
Income Before Tax
-12
-8
-11
-19
Income Tax Expense
-
0
-
-
Net Income
-9
-8
-8
-13
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Satellos Bioscience Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-3
-6
-5
-5
Operating Cash Flow
-4
-7
-4
-4
Investing Cash Flow
-8
-
8
-15
Financing Cash Flow
37
0
1
0
Change in Cash
22
-7
5
-18

Satellos Bioscience Inc Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Net Income
-8
-11
-19
Operating Cash Flow
-4
-8
-17
Investing Cash Flow
0
-13
4
Financing Cash Flow
2
38
37
Change in Cash
-2
15
24

Insights on Satellos Bioscience Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, MSLE stock has moved down by -14.5%

About Satellos Bioscience Inc

Satellos is a biotechnology company founded on game changing science in skeletal muscle regeneration. Our vision is to invent and develop medicines which reset the body's innate ability for self-repair as a truly novel approach for the treatment of devastating muscle disorders.
OrganisationSatellos Bioscience Inc
HeadquartersRoyal Bank Plaza, Toronto, ON, Canada, M5J 2J1
CEOMr. Francis Gleeson B.B.A. M.B.A
E-voting on sharesClick here to vote

Key Management of Satellos Bioscience Inc

Name

Title

Mr. Michael Liggett B.Sc., Bsc. Pharm., C.A., C.P.A.

Strategic Advisor

Mr. Warren Whitehead C.M.A., CPA

Head of Corporate Strategy

Dr. Wildon Farwell M.D., M.P.H.

Chief Medical Officer

Dr. Philip Lambert M.A., Ph.D.

Chief Scientific Officer

Ms. Elizabeth Williams C.A., CPA

CFO & Corporate Secretary

Dr. Michael A. Rudnicki Ph.D.

Co-Founder & Chief Discovery Officer

Mr. J. Robert Hall CFA

Senior Vice President of Finance & Administration

Dr. Ryan Mitchell Ph.D.

Senior VP & Head of Corporate Development

Ms. Desiree Chan

Chief of Staff

Mr. Francis Gleeson B.B.A. M.B.A

Co-Founder, CEO, President & Director

FAQs

What is Satellos Bioscience Inc share price today?

Satellos Bioscience Inc share price today is $6.2 as on at the close of the market. Satellos Bioscience Inc share today touched a day high of $7 and a low of $6.1.

What is the 52 week high and 52 week low for Satellos Bioscience Inc share?

Satellos Bioscience Inc share touched a 52 week high of $ on and a 52 week low of $ on . Satellos Bioscience Inc stock price today i.e. is closed at $6.2,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Satellos Bioscience Inc's market capitalisation today?

Satellos Bioscience Inc market capitalisation is $0.00T as on .

How to invest in Satellos Bioscience Inc Stock (MSLE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Satellos Bioscience Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Satellos Bioscience Inc Shares that will get you 0.2419 shares as per Satellos Bioscience Inc share price of $6.2 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Satellos Bioscience Inc Stock (MSLE) from India?

Indian investors can start investing in Satellos Bioscience Inc (MSLE) shares with as little as ₹94.651 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.51 in Satellos Bioscience Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Satellos Bioscience Inc share’s latest price of $6.2 as on March 28, 2026 at 1:29 am IST, you will get 1.6129 shares of Satellos Bioscience Inc. Learn more about fractional shares .